Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Linema Pharm — a Tbilisi-based wholesaler and importer of medical devices, equipment and consumables for clinics, doctors and nurses (incl. orthopedic devices; imports largely from India; linema.ge). A medical-supply distributor rather than a pharmacy.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| 4,322 | 2,084 | 3,921 | 3,578 | 1,620 | 3,886 | -2.1% | |
| Total COGS | 2,637 | 1,237 | 2,440 | 2,095 | 869 | 2,336 | -2.4% |
| Gross Profit | 1,685 | 847 | 1,480 | 1,483 | 752 | 1,550 | -1.7% |
| Gross Margin | 39.0% | 40.6% | 37.8% | 41.4% | 46.4% | 39.9% | |
| 447 | 245 | 109 | 0 | 286 | 299 | -7.7% | |
| EBITDA | 1,238 | 602 | 1,589 | 1,483 | 465 | 1,251 | +0.2% |
| EBITDA Margin | 28.7% | 28.9% | 40.5% | 41.4% | 28.7% | 32.2% | |
| Total D&A | 1 | 17 | 15 | 48 | 61 | 65 | +150.6% |
| EBIT / Operating Income | 1,238 | 584 | 1,574 | 1,435 | 405 | 1,186 | -0.9% |
| Total Interest Income | 0 | 0 | 0 | 0 | 0 | 190 | |
| Total Interest Expense | 0 | 0 | 3 | 13 | 4 | 169 | +291.2% |
| Total Other Income | 0 | 0 | 201 | 52 | 487 | 0 | nmf |
| Profit Before Tax | 1,238 | 584 | 1,771 | 1,474 | 86 | 1,206 | -0.5% |
| Total Income Tax | 173 | 3 | 7 | 1 | 1 | 0 | nmf |
| Net Profit / (Loss) | 1,065 | 581 | 1,526 | 1,307 | 90 | 1,206 | +2.5% |
| Net Margin | 24.6% | 27.9% | 38.9% | 36.5% | 5.5% | 31.0% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →